pET22b-DS55
(Plasmid
#187175)
-
Purpose(Empty Backbone) This modified pET22b-DS55 vector contains Sal I and Hind III sites in reverse orientations to directly clone scFv phagemid from HuScL-4 library for bacterial expression systems.
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 187175 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 |
Backbone
-
Vector backbonepET22b(+)
-
Backbone manufacturerNovagen
- Backbone size (bp) 5493
-
Modifications to backboneNco I, Hind III, BamH I, Sal I, Xho I followed by 6 His tag
-
Vector typeBacterial Expression
- Promoter AmpR, lac1
-
Tag
/ Fusion Protein
- His tag (C terminal on backbone)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer T7 promoter
- 3′ sequencing primer T7 terminator (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byWe have modified pET22b(+) vector backbone MCS to directly clone scFv phagemid from HuScL-4 library.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The modification in the MCS of pET22b(+) are as follows:
Nco I, Hind III, BamH I, Sal I, Xho I followed by 6 His tag (C-ter).
Please visit https://doi.org/10.1101/2025.07.15.663531 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET22b-DS55 was a gift from Dinakar Salunke (Addgene plasmid # 187175 ; http://n2t.net/addgene:187175 ; RRID:Addgene_187175) -
For your References section:
Immunologic insights into the critical epitopes of HIV-1 and structure-based characterization of cross-reactive antibodies. Jaiswal D, Verma S, Madni ZK, Kaur G, Kaur KJ, Salunke DM. bioRxiv 2025.07.15.663531 10.1101/2025.07.15.663531